Vir Biotechnology, Inc.
VIR stock score: 57/100
$11.93 · +3.11% · Scored Oct 28, 2026
- Technical
- 68
- Fundamental
- 47
- News
- —
The reading
Vir Biotechnology (VIR) scores 57 out of 100, which reads neutral, higher than 80% of Healthcare stocks and 65% of the 4,156 US stocks we score.
The composite is technicals and fundamentals weighted equally: technicals read 68, fundamentals 47.
Among the fundamentals, Quick Ratio at 100 and Price Target at 100 score highest, while Earnings Quality (Annual) at 0 weighs the most against it.
On the daily chart, trend-following indicators average 71 and contrarian oscillators 40 — a split worth reading before trusting the technical total.
Since Jul 31, 2026 the composite has ranged from 49 to 66, and it is down 9 points over the period.
What’s driving the score
The strongest and weakest of the scorers that count toward VIR’s composite. Each returns 0–100, higher is more bullish — including metrics where low is good, like P/E.
Fundamental
47Pulling it up
- Quick Ratio100
Quick ratio measures a company's ability to meet short-term obligations with liquid assets.
- Price Target100
Price target score compares the current stock price to analyst consensus targets.
- Current Ratio100
Current ratio measures ability to pay short-term liabilities with current assets.
Holding it back
- Earnings Quality (Annual)0
Earnings Quality (Annual) assesses absolute profitability independent of growth, measuring whether the company is profitable, its earnings yield (earnings/market cap), profit margins, and consistency.
- Earnings Growth (5-Year)0
5-year earnings growth evaluates long-term profit trajectory and consistency.
- Free Cash Flow Yield0
Free cash flow yield is free cash flow divided by market value: the cash a business generates for each dollar of its price.
38 weighted scorers; 3 had no data today and are left out rather than counted as zero.
Technical · daily
68Pulling it up
- Parabolic SAR (PSAR)100
Parabolic SAR (Stop and Reverse) provides trailing stop levels that follow price trends.
- VWAP100
Volume Weighted Average Price (VWAP) shows the average price weighted by volume.
- 52-Week Range100
Where the price sits between its 52-week low and high.
Holding it back
- Bollinger Bands (50)3
Bollinger Bands (50-period) measure where price sits between bands two standard deviations around its 50-period average.
- Bollinger Bands (20)9
Bollinger Bands (20-period) plot standard deviations above and below a moving average.
- Williams %R (7)12
Williams %R (7-period) places the close within the last 7 periods' high-low range.
62 weighted scorers; 3 had no data today and are left out rather than counted as zero.
Technical score by timeframe
| Chart | Score | Weight |
|---|---|---|
| Hourly | 64 | 1 |
| Daily | 68 | 3 |
| Weekly | 69 | 2 |
| Monthly | 71 | 2 |
| Quarterly | 66 | 2 |
Composite score, last 90 days
Show the daily numbers
| Date | Composite |
|---|---|
| Oct 28, 2026 | 57 |
| Oct 27, 2026 | 57 |
| Oct 26, 2026 | 56 |
| Oct 25, 2026 | 53 |
| Oct 24, 2026 | 53 |
| Oct 23, 2026 | 53 |
| Oct 22, 2026 | 52 |
| Oct 21, 2026 | 54 |
| Oct 20, 2026 | 54 |
| Oct 19, 2026 | 51 |
| Oct 18, 2026 | 51 |
| Oct 17, 2026 | 51 |
| Oct 16, 2026 | 51 |
| Oct 15, 2026 | 53 |
| Oct 14, 2026 | 53 |
| Oct 13, 2026 | 53 |
| Oct 12, 2026 | 56 |
| Oct 11, 2026 | 57 |
| Oct 10, 2026 | 57 |
| Oct 9, 2026 | 57 |
| Oct 8, 2026 | 55 |
| Oct 7, 2026 | 57 |
| Oct 6, 2026 | 58 |
| Oct 5, 2026 | 57 |
| Oct 4, 2026 | 56 |
| Oct 3, 2026 | 56 |
| Oct 2, 2026 | 56 |
| Oct 1, 2026 | 57 |
| Sep 30, 2026 | 56 |
| Sep 29, 2026 | 54 |
| Sep 28, 2026 | 53 |
| Sep 27, 2026 | 53 |
| Sep 26, 2026 | 53 |
| Sep 25, 2026 | 55 |
| Sep 24, 2026 | 55 |
| Sep 23, 2026 | 58 |
| Sep 22, 2026 | 57 |
| Sep 21, 2026 | 56 |
| Sep 20, 2026 | 54 |
| Sep 19, 2026 | 54 |
| Sep 18, 2026 | 54 |
| Sep 17, 2026 | 55 |
| Sep 16, 2026 | 53 |
| Sep 15, 2026 | 53 |
| Sep 14, 2026 | 54 |
| Sep 13, 2026 | 55 |
| Sep 12, 2026 | 55 |
| Sep 11, 2026 | 55 |
| Sep 10, 2026 | 54 |
| Sep 9, 2026 | 54 |
| Sep 8, 2026 | 56 |
| Sep 7, 2026 | 57 |
| Sep 6, 2026 | 57 |
| Sep 5, 2026 | 57 |
| Sep 4, 2026 | 56 |
| Sep 3, 2026 | 57 |
| Sep 2, 2026 | 56 |
| Sep 1, 2026 | 57 |
| Aug 31, 2026 | 56 |
| Aug 30, 2026 | 56 |
| Aug 29, 2026 | 56 |
| Aug 28, 2026 | 55 |
| Aug 27, 2026 | 57 |
| Aug 26, 2026 | 57 |
| Aug 25, 2026 | 57 |
| Aug 24, 2026 | 56 |
| Aug 23, 2026 | 55 |
| Aug 19, 2026 | 57 |
| Aug 18, 2026 | 56 |
| Aug 17, 2026 | 56 |
| Aug 16, 2026 | 54 |
| Aug 15, 2026 | 54 |
| Aug 14, 2026 | 54 |
| Aug 13, 2026 | 54 |
| Aug 12, 2026 | 52 |
| Aug 11, 2026 | 51 |
| Aug 10, 2026 | 52 |
| Aug 9, 2026 | 50 |
| Aug 8, 2026 | 50 |
| Aug 7, 2026 | 49 |
| Aug 6, 2026 | 51 |
| Aug 5, 2026 | 55 |
| Aug 3, 2026 | 51 |
| Aug 2, 2026 | 50 |
| Jul 31, 2026 | 66 |
Key facts
- Market cap
- $2.0B
- Sector
- Healthcare
- Industry
- Biotechnology
- Beta
- 1.59
- Risk grade (1–10)
- 8
- Next earnings
- Nov 4, 2026
Biotechnology peers
| Company | Market cap | Score |
|---|---|---|
| VCEL Vericel | $2.1B | 57 |
| SLS SELLAS Life Sciences Group | $2.1B | 46 |
| ZYME Zymeworks | $2.1B | 52 |
| SEPN Septerna | $2.1B | 60 |
| SRPT Sarepta Therapeutics | $2.0B | 39 |
| ABSI Absci | $2.0B | 47 |
Questions
What is VIR's stock score today?
VIR scores 57/100 (Neutral) as of Oct 28, 2026: technical 68, fundamental 47. Scores are recomputed every night.
Is VIR a buy?
The score is not a buy or sell recommendation. A 57 says the technical and fundamental signals we measure lean neutral today, relative to every other stock scored the same way. Use the breakdown above to see why, and treat it as a starting point for your own research.
How is the VIR score calculated?
100 weighted scorers feed it today: 38 fundamental, scored against Healthcare ranges, and 62 technical on the daily chart, with 5 timeframes blended into the technical total. Every scorer returns 0–100; missing data is left out, never counted as zero.
Scores are information, not investment advice. Computed from Yahoo Finance, Finnhub and Alpha Vantage data; technical indicators via TA-Lib. Past scores do not predict future returns.